The proposed research has its long term goal elucidation of the contributions of Epstein-Barr virus (EBV) to the human cancers with which it is associated. Many observations indicated that EBV contributes to human lymphoid tumors by initiating and maintaining proliferation of the infected B-lymphocyte. Two of the viral proteins that appear essential for these events are Epstein-Barr nuclear antigen type 1 (EBNA-1) and latent membrane protein type 1 (LMP-1). During the current funding period biochemical properties and functions of EBNA-1 and LMP-1 have been identified. These properties and functions will be elucidated mechanistically in the research proposed in this application using many of the assays and reagents developed during the current funding period. EBNA- 1 is required for replication of EBV's genome as a plasmid in proliferating cells. The mechanism by which it supports plasmid replication will be established. The role that EBNA-1's linking function contributes to EBNA-1's support of replication and transcription will be analyzed. The hypothesis that this linking function contributes to the partitioning of viral genomes in proliferating cells will be tested. The second protein, LMP-1, has been hypothesize to behave as an oncogene by its constitutive signaling at the plasma membrane. The role of both the amino-terminal and carboxy-terminal cytoplasmic moieties of this onco- protein in signaling will be investigated. These studies on individual transforming genes of EBV will be complemented by the development of new methods to analyze EBV genetically so that insights gained from the study of specific viral genes can be extended readily to their study in the context of the whole virus.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA022443-25
Application #
6590250
Study Section
Project Start
2002-05-01
Project End
2003-04-30
Budget Start
Budget End
Support Year
25
Fiscal Year
2002
Total Cost
$183,401
Indirect Cost
Name
University of Wisconsin Madison
Department
Type
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715
Weng, Chao; Lee, Denis; Gelbmann, Christopher B et al. (2018) Human Cytomegalovirus Productively Replicates In Vitro in Undifferentiated Oral Epithelial Cells. J Virol 92:
Bristol, Jillian A; Djavadian, Reza; Albright, Emily R et al. (2018) A cancer-associated Epstein-Barr virus BZLF1 promoter variant enhances lytic infection. PLoS Pathog 14:e1007179
Romero-Masters, James C; Ohashi, Makoto; Djavadian, Reza et al. (2018) An EBNA3C-deleted Epstein-Barr virus (EBV) mutant causes B-cell lymphomas with delayed onset in a cord blood-humanized mouse model. PLoS Pathog 14:e1007221
UmaƱa, Angie C; Iwahori, Satoko; Kalejta, Robert F (2018) Direct Substrate Identification with an Analog Sensitive (AS) Viral Cyclin-Dependent Kinase (v-Cdk). ACS Chem Biol 13:189-199
Meyers, Jordan M; Grace, Miranda; Uberoi, Aayushi et al. (2018) Inhibition of TGF-? and NOTCH Signaling by Cutaneous Papillomaviruses. Front Microbiol 9:389
Uberoi, Aayushi; Yoshida, Satoshi; Lambert, Paul F (2018) Development of an in vivo infection model to study Mouse papillomavirus-1 (MmuPV1). J Virol Methods 253:11-17
Djavadian, Reza; Hayes, Mitchell; Johannsen, Eric (2018) CAGE-seq analysis of Epstein-Barr virus lytic gene transcription: 3 kinetic classes from 2 mechanisms. PLoS Pathog 14:e1007114
Chakravorty, Adityarup; Sugden, Bill (2018) Long-distance communication: Looping of human papillomavirus genomes regulates expression of viral oncogenes. PLoS Biol 16:e3000062
Chiu, Ya-Fang; Sugden, Bill (2018) Plasmid Partitioning by Human Tumor Viruses. J Virol 92:
Shin, Myeong-Kyun; Payne, Susan N; Bilger, Andrea et al. (2018) Activating Mutations in Pik3caContribute to Anal Carcinogenesis in the Presence or Absence of HPV-16 Oncogenes. Clin Cancer Res :

Showing the most recent 10 out of 434 publications